Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Collins

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Letters|September 10, 2010
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer modelKimberley A Stannard, Patrick M Collins, Koichi Ito, et al.
Journal of Visualized Experiments : Jove|June 14, 2021
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light SourceAlice Douangamath, Ailsa Powell, Daren Fearon, et al.
ACS Chemical Biology|October 19, 2017
Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based ApproachesPatrick J McIntyre, Patrick M Collins, Lukáš Vrzal, et al.
BJS Open|November 5, 2025
Effect of sarcopenia on treatment response and operative and oncological outcomes among patients undergoing neoadjuvant chemotherapy for breast cancerThomas O Butler, Jessie A Elliott, Matthew G Davey, et al.
Bioorganic & Medicinal Chemistry|April 16, 2018
Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamasesDong Zhang, Marios S Markoulides, Dmitrijs Stepanovs, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Scientific Reports|September 29, 2021
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Letters|September 10, 2010
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer modelKimberley A Stannard, Patrick M Collins, Koichi Ito, et al.
Journal of Visualized Experiments : Jove|June 14, 2021
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light SourceAlice Douangamath, Ailsa Powell, Daren Fearon, et al.
ACS Chemical Biology|October 19, 2017
Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based ApproachesPatrick J McIntyre, Patrick M Collins, Lukáš Vrzal, et al.
BJS Open|November 5, 2025
Effect of sarcopenia on treatment response and operative and oncological outcomes among patients undergoing neoadjuvant chemotherapy for breast cancerThomas O Butler, Jessie A Elliott, Matthew G Davey, et al.
Bioorganic & Medicinal Chemistry|April 16, 2018
Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamasesDong Zhang, Marios S Markoulides, Dmitrijs Stepanovs, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Scientific Reports|September 29, 2021
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Pageof 3